Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 114 entries
Sorted by: Best Match Show Resources per page
Analytical chemistry in Europe and international tendencies : The accreditation of analytical laboratories- Quality assurance in analytical chemistry.

Environmental science and pollution research international

Günzler H.
PMID: 24234151
Environ Sci Pollut Res Int. 1994 Jan;1(1):56-7. doi: 10.1007/BF02986928.

No abstract available.

Cite
Günzler H. Analytical chemistry in Europe and international tendencies : The accreditation of analytical laboratories- Quality assurance in analytical chemistry. Environ Sci Pollut Res Int. 1994;1(1):56-7doi: 10.1007/BF02986928.
Günzler, H. (1994). Analytical chemistry in Europe and international tendencies : The accreditation of analytical laboratories- Quality assurance in analytical chemistry. Environmental science and pollution research international, 1(1), 56-7. https://doi.org/10.1007/BF02986928
Günzler, H. "Analytical chemistry in Europe and international tendencies : The accreditation of analytical laboratories- Quality assurance in analytical chemistry." Environmental science and pollution research international vol. 1,1 (1994): 56-7. doi: https://doi.org/10.1007/BF02986928
Günzler H. Analytical chemistry in Europe and international tendencies : The accreditation of analytical laboratories- Quality assurance in analytical chemistry. Environ Sci Pollut Res Int. 1994 Jan;1(1):56-7. doi: 10.1007/BF02986928. PMID: 24234151.
Copy Download .nbib Format: NLM
The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure.

Biostatistics (Oxford, England)

Law NJ, Taylor JM, Sandler H.
PMID: 12933597
Biostatistics. 2002 Dec;3(4):547-63. doi: 10.1093/biostatistics/3.4.547.

In this paper we present an extension of cure models: to incorporate a longitudinal disease progression marker. The model is motivated by studies of patients with prostate cancer undergoing radiation therapy. The patients are followed until recurrence of the...

Cite
Law NJ, Taylor JM, Sandler H. The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. Biostatistics. 2002;3(4):547-63doi: 10.1093/biostatistics/3.4.547.
Law, N. J., Taylor, J. M., & Sandler, H. (2002). The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. Biostatistics (Oxford, England), 3(4), 547-63. https://doi.org/10.1093/biostatistics/3.4.547
Law, Ngayee J, et al. "The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure." Biostatistics (Oxford, England) vol. 3,4 (2002): 547-63. doi: https://doi.org/10.1093/biostatistics/3.4.547
Law NJ, Taylor JM, Sandler H. The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. Biostatistics. 2002 Dec;3(4):547-63. doi: 10.1093/biostatistics/3.4.547. PMID: 12933597.
Copy Download .nbib Format: NLM
Concentration Gradients of trans-Zeatin Riboside and trans-Zeatin in the Maize Stem: Measurement by a Specific Enzyme Immunoassay.

Plant physiology

Hansen CE, Wenzler H, Meins F.
PMID: 16663768
Plant Physiol. 1984 Aug;75(4):959-63. doi: 10.1104/pp.75.4.959.

A sensitive, specific enzyme immunoassay (EIA) for trans-zeatin riboside (ZR) and trans-zeatin (Z) in the 0.3 to 30 picomole range has been described. The reliability of the method for measuring ZR + Z in partially purified extracts of Zea...

Cite
Hansen CE, Wenzler H, Meins F. Concentration Gradients of trans-Zeatin Riboside and trans-Zeatin in the Maize Stem: Measurement by a Specific Enzyme Immunoassay. Plant Physiol. 1984;75(4):959-63doi: 10.1104/pp.75.4.959.
Hansen, C. E., Wenzler, H., & Meins, F. (1984). Concentration Gradients of trans-Zeatin Riboside and trans-Zeatin in the Maize Stem: Measurement by a Specific Enzyme Immunoassay. Plant physiology, 75(4), 959-63. https://doi.org/10.1104/pp.75.4.959
Hansen, C E, et al. "Concentration Gradients of trans-Zeatin Riboside and trans-Zeatin in the Maize Stem: Measurement by a Specific Enzyme Immunoassay." Plant physiology vol. 75,4 (1984): 959-63. doi: https://doi.org/10.1104/pp.75.4.959
Hansen CE, Wenzler H, Meins F. Concentration Gradients of trans-Zeatin Riboside and trans-Zeatin in the Maize Stem: Measurement by a Specific Enzyme Immunoassay. Plant Physiol. 1984 Aug;75(4):959-63. doi: 10.1104/pp.75.4.959. PMID: 16663768; PMCID: PMC1067032.
Copy Download .nbib Format: NLM
Metabolic responses to lipid infusions in patients with liver cirrhosis.

Clinical nutrition (Edinburgh, Scotland)

Müller MJ, Rieger A, Willmann O, Lautz HU, Balks HJ, Von Zur Mühlen A, Canzler H, Schmidt FW.
PMID: 16839998
Clin Nutr. 1992 Aug;11(4):193-206. doi: 10.1016/0261-5614(92)90028-o.

Energy expenditure, whole body substrate oxidation rates and arterial substrate concentrations were measured in 14 patients with liver cirrhosis and 13 control subjects before and during sequential infusions of a long chain (LCT) or a medium chain triglyceride emulsion...

Cite
Müller MJ, Rieger A, Willmann O, et al. Metabolic responses to lipid infusions in patients with liver cirrhosis. Clin Nutr. 1992;11(4):193-206doi: 10.1016/0261-5614(92)90028-o.
Müller, M. J., Rieger, A., Willmann, O., Lautz, H. U., Balks, H. J., Von Zur Mühlen, A., Canzler, H., & Schmidt, F. W. (1992). Metabolic responses to lipid infusions in patients with liver cirrhosis. Clinical nutrition (Edinburgh, Scotland), 11(4), 193-206. https://doi.org/10.1016/0261-5614(92)90028-o
Müller, M J, et al. "Metabolic responses to lipid infusions in patients with liver cirrhosis." Clinical nutrition (Edinburgh, Scotland) vol. 11,4 (1992): 193-206. doi: https://doi.org/10.1016/0261-5614(92)90028-o
Müller MJ, Rieger A, Willmann O, Lautz HU, Balks HJ, Von Zur Mühlen A, Canzler H, Schmidt FW. Metabolic responses to lipid infusions in patients with liver cirrhosis. Clin Nutr. 1992 Aug;11(4):193-206. doi: 10.1016/0261-5614(92)90028-o. PMID: 16839998.
Copy Download .nbib Format: NLM
Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.

Clinical medicine. Oncology

Sprinzl MF, Wytopil SM, Dahmen A, Kanzler S, Galle PR, Moehler M.
PMID: 21892332
Clin Med Oncol. 2008;2:555-61. doi: 10.4137/cmo.s919. Epub 2008 Dec 03.

INTRODUCTION: Despite many efforts to develop new chemotherapies for metastatic upper gastrointestinal (GI) cancer, overall prognosis continues to be fatal, particularly in gastric and pancreatic cancer. Many of these patients deserve second-or third-line treatment after failure of first-line chemotherapy....

Cite
Sprinzl MF, Wytopil SM, Dahmen A, et al. Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas. Clin Med Oncol. 2008;2:555-61doi: 10.4137/cmo.s919.
Sprinzl, M. F., Wytopil, S. M., Dahmen, A., Kanzler, S., Galle, P. R., & Moehler, M. (2008). Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas. Clinical medicine. Oncology, 2555-61. https://doi.org/10.4137/cmo.s919
Sprinzl, Martin F, et al. "Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas." Clinical medicine. Oncology vol. 2 (2008): 555-61. doi: https://doi.org/10.4137/cmo.s919
Sprinzl MF, Wytopil SM, Dahmen A, Kanzler S, Galle PR, Moehler M. Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas. Clin Med Oncol. 2008;2:555-61. doi: 10.4137/cmo.s919. Epub 2008 Dec 03. PMID: 21892332; PMCID: PMC3161696.
Copy Download .nbib Format: NLM
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.
PMID: 30307776
J Clin Oncol. 2018 Oct 11;JCO1801097. doi: 10.1200/JCO.18.01097. Epub 2018 Oct 11.

No abstract available.

Cite
Morgan SC, Hoffman K, Loblaw DA, et al. Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. J Clin Oncol. 2018;JCO1801097doi: 10.1200/JCO.18.01097.
Morgan, S. C., Hoffman, K., Loblaw, D. A., Buyyounouski, M. K., Patton, C., Barocas, D., Bentzen, S., Chang, M., Efstathiou, J., Greany, P., Halvorsen, P., Koontz, B. F., Lawton, C., Leyrer, C. M., Lin, D., Ray, M., & Sandler, H. (2018). Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO1801097. https://doi.org/10.1200/JCO.18.01097
Morgan, Scott C, et al. "Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2018): JCO1801097. doi: https://doi.org/10.1200/JCO.18.01097
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H. Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. J Clin Oncol. 2018 Oct 11;JCO1801097. doi: 10.1200/JCO.18.01097. Epub 2018 Oct 11. PMID: 30307776; PMCID: PMC6269129.
Copy Download .nbib Format: NLM
Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.

Journal of gastrointestinal oncology

Yue Y, Osipov A, Fraass B, Sandler H, Zhang X, Nissen N, Hendifar A, Tuli R.
PMID: 28280617
J Gastrointest Oncol. 2017 Feb;8(1):127-138. doi: 10.21037/jgo.2016.12.04.

BACKGROUND: To stratify risks of pancreatic adenocarcinoma (PA) patients using pre- and post-radiotherapy (RT) PET/CT images, and to assess the prognostic value of texture variations in predicting therapy response of patients.METHODS: Twenty-six PA patients treated with RT from 2011-2013...

Cite
Yue Y, Osipov A, Fraass B, et al. Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol. 2017;8(1):127-138doi: 10.21037/jgo.2016.12.04.
Yue, Y., Osipov, A., Fraass, B., Sandler, H., Zhang, X., Nissen, N., Hendifar, A., & Tuli, R. (2017). Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. Journal of gastrointestinal oncology, 8(1), 127-138. https://doi.org/10.21037/jgo.2016.12.04
Yue, Yong, et al. "Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients." Journal of gastrointestinal oncology vol. 8,1 (2017): 127-138. doi: https://doi.org/10.21037/jgo.2016.12.04
Yue Y, Osipov A, Fraass B, Sandler H, Zhang X, Nissen N, Hendifar A, Tuli R. Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol. 2017 Feb;8(1):127-138. doi: 10.21037/jgo.2016.12.04. PMID: 28280617; PMCID: PMC5334038.
Copy Download .nbib Format: NLM
Tracheostomy care and communication during COVID-19: Global interprofessional perspectives.

American journal of otolaryngology

Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V.
PMID: 34968814
Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23.

OBJECTIVE: Investigate healthcare providers, caregivers, and patient perspectives on tracheostomy care barriers during COVID-19.STUDY DESIGN: Cross-sectional anonymous survey SETTING: Global Tracheostomy Collaborative Learning Community METHODS: A 17-item questionnaire was electronically distributed, assessing demographic and occupational data; challenges in ten...

Cite
Moser CH, Freeman-Sanderson A, Keeven E, et al. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021;43(2):103354doi: 10.1016/j.amjoto.2021.103354.
Moser, C. H., Freeman-Sanderson, A., Keeven, E., Higley, K. A., Ward, E., Brenner, M. J., & Pandian, V. (2021). Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. American journal of otolaryngology, 43(2), 103354. https://doi.org/10.1016/j.amjoto.2021.103354
Moser, Chandler H, et al. "Tracheostomy care and communication during COVID-19: Global interprofessional perspectives." American journal of otolaryngology vol. 43,2 (2021): 103354. doi: https://doi.org/10.1016/j.amjoto.2021.103354
Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23. PMID: 34968814.
Copy Download .nbib Format: NLM
Host Mitochondrial Requirements of Cytomegalovirus Replication.

Current clinical microbiology reports

Monk CH, Zwezdaryk KJ.
PMID: 33816061
Curr Clin Microbiol Rep. 2020 Dec;7(4):115-123. doi: 10.1007/s40588-020-00153-5. Epub 2020 Sep 30.

PURPOSE OF REVIEW: Metabolic rewiring of the host cell is required for optimal viral replication. Human cytomegalovirus (HCMV) has been observed to manipulate numerous mitochondrial functions. In this review, we describe the strategies and targets HCMV uses to control...

Cite
Monk CH, Zwezdaryk KJ. Host Mitochondrial Requirements of Cytomegalovirus Replication. Curr Clin Microbiol Rep. 2020;7(4):115-123doi: 10.1007/s40588-020-00153-5.
Monk, C. H., & Zwezdaryk, K. J. (2020). Host Mitochondrial Requirements of Cytomegalovirus Replication. Current clinical microbiology reports, 7(4), 115-123. https://doi.org/10.1007/s40588-020-00153-5
Monk, Chandler H, and Zwezdaryk, Kevin J. "Host Mitochondrial Requirements of Cytomegalovirus Replication." Current clinical microbiology reports vol. 7,4 (2020): 115-123. doi: https://doi.org/10.1007/s40588-020-00153-5
Monk CH, Zwezdaryk KJ. Host Mitochondrial Requirements of Cytomegalovirus Replication. Curr Clin Microbiol Rep. 2020 Dec;7(4):115-123. doi: 10.1007/s40588-020-00153-5. Epub 2020 Sep 30. PMID: 33816061; PMCID: PMC8015347.
Copy Download .nbib Format: NLM
Tracheostomy care and communication during COVID-19: Global interprofessional perspectives.

American journal of otolaryngology

Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V.
PMID: 34968814
Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23.

OBJECTIVE: Investigate healthcare providers, caregivers, and patient perspectives on tracheostomy care barriers during COVID-19.STUDY DESIGN: Cross-sectional anonymous survey SETTING: Global Tracheostomy Collaborative Learning Community METHODS: A 17-item questionnaire was electronically distributed, assessing demographic and occupational data; challenges in ten...

Cite
Moser CH, Freeman-Sanderson A, Keeven E, et al. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021;43(2):103354doi: 10.1016/j.amjoto.2021.103354.
Moser, C. H., Freeman-Sanderson, A., Keeven, E., Higley, K. A., Ward, E., Brenner, M. J., & Pandian, V. (2021). Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. American journal of otolaryngology, 43(2), 103354. https://doi.org/10.1016/j.amjoto.2021.103354
Moser, Chandler H, et al. "Tracheostomy care and communication during COVID-19: Global interprofessional perspectives." American journal of otolaryngology vol. 43,2 (2021): 103354. doi: https://doi.org/10.1016/j.amjoto.2021.103354
Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23. PMID: 34968814; PMCID: PMC8695522.
Copy Download .nbib Format: NLM
Tracheostomy care and communication during COVID-19: Global interprofessional perspectives.

American journal of otolaryngology

Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V.
PMID: 34968814
Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23.

OBJECTIVE: Investigate healthcare providers, caregivers, and patient perspectives on tracheostomy care barriers during COVID-19.STUDY DESIGN: Cross-sectional anonymous survey SETTING: Global Tracheostomy Collaborative Learning Community METHODS: A 17-item questionnaire was electronically distributed, assessing demographic and occupational data; challenges in ten...

Cite
Moser CH, Freeman-Sanderson A, Keeven E, et al. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021;43(2):103354doi: 10.1016/j.amjoto.2021.103354.
Moser, C. H., Freeman-Sanderson, A., Keeven, E., Higley, K. A., Ward, E., Brenner, M. J., & Pandian, V. (2021). Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. American journal of otolaryngology, 43(2), 103354. https://doi.org/10.1016/j.amjoto.2021.103354
Moser, Chandler H, et al. "Tracheostomy care and communication during COVID-19: Global interprofessional perspectives." American journal of otolaryngology vol. 43,2 (2021): 103354. doi: https://doi.org/10.1016/j.amjoto.2021.103354
Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23. PMID: 34968814; PMCID: PMC8695522.
Copy Download .nbib Format: NLM
Tracheostomy care and communication during COVID-19: Global interprofessional perspectives.

American journal of otolaryngology

Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V.
PMID: 34968814
Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23.

OBJECTIVE: Investigate healthcare providers, caregivers, and patient perspectives on tracheostomy care barriers during COVID-19.STUDY DESIGN: Cross-sectional anonymous survey SETTING: Global Tracheostomy Collaborative Learning Community METHODS: A 17-item questionnaire was electronically distributed, assessing demographic and occupational data; challenges in ten...

Cite
Moser CH, Freeman-Sanderson A, Keeven E, et al. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021;43(2):103354doi: 10.1016/j.amjoto.2021.103354.
Moser, C. H., Freeman-Sanderson, A., Keeven, E., Higley, K. A., Ward, E., Brenner, M. J., & Pandian, V. (2021). Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. American journal of otolaryngology, 43(2), 103354. https://doi.org/10.1016/j.amjoto.2021.103354
Moser, Chandler H, et al. "Tracheostomy care and communication during COVID-19: Global interprofessional perspectives." American journal of otolaryngology vol. 43,2 (2021): 103354. doi: https://doi.org/10.1016/j.amjoto.2021.103354
Moser CH, Freeman-Sanderson A, Keeven E, Higley KA, Ward E, Brenner MJ, Pandian V. Tracheostomy care and communication during COVID-19: Global interprofessional perspectives. Am J Otolaryngol. 2021 Dec 23;43(2):103354. doi: 10.1016/j.amjoto.2021.103354. Epub 2021 Dec 23. PMID: 34968814; PMCID: PMC8695522.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 114 entries